Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boon Cher Goh

Showing results (171-180 of 242) with videos related to

Pageof 25
Sort By:
Pharmacogenetics and Genomics|October 8, 2009
Post-treatment tumor gene expression signatures are more predictive of treatment outcomes than baseline signatures in breast cancerSoo-Chin Lee, Xin Xu, Wee-Joo Chng, et al.
Oncotarget|March 13, 2015
Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkersFeng Li, Muthu K Shanmugam, Kodappully Sivaraman Siveen, et al.
British Journal of Clinical Pharmacology|October 10, 2020
Intracellular vincristine levels in lymphoblasts affect treatment outcome in childhood B-lymphoblastic leukaemia: Ma-Spore ALL 2010 studyNan Jiang, Lingzhi Wang, Xiaoqiang Xiang, et al.
Scientific Reports|June 15, 2016
Pharmacogenetics-Guided Phase I Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid TumoursRoss Andrew Soo, Nicholas Syn, Soo-Chin Lee, et al.
Antioxidants & Redox Signaling|August 23, 2013
Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinomaAlan Prem Kumar, Ser Yue Loo, Sung Won Shin, et al.
Theranostics|January 4, 2021
Putting the BRK on breast cancer: From molecular target to therapeuticsHui Li Ang, Yi Yuan, Xianning Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2026
A multicentre phase 2 study of trifluridine/tipiracil in recurrent/metastatic platinum resistant nasopharyngeal carcinomasJia Li Low, Wan Qin Chong, Edwin Pun Hui, et al.
Cancer Letters|July 28, 2016
A novel combinatorial strategy using Seliciclib(®) and Belinostat(®) for eradication of non-small cell lung cancer via apoptosis induction and BID activationPei-Shi Ong, Lingzhi Wang, Deborah Miao-Hui Chia, et al.
Oncotarget|February 4, 2017
Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1Lingzhi Wang, Chong En Linus Chan, Andrea Li-Ann Wong, et al.
Cancer|April 2, 2019
Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potentialRahel Sarah Varughese, Walter Sze-Tung Lam, Ahmad Abdurrahman Bin Hanifah Marican, et al.
Pageof 25

Showing results (171-180 of 242) with videos related to

Sort By:
Pageof 25
Pharmacogenetics and Genomics|October 8, 2009
Post-treatment tumor gene expression signatures are more predictive of treatment outcomes than baseline signatures in breast cancerSoo-Chin Lee, Xin Xu, Wee-Joo Chng, et al.
Oncotarget|March 13, 2015
Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkersFeng Li, Muthu K Shanmugam, Kodappully Sivaraman Siveen, et al.
British Journal of Clinical Pharmacology|October 10, 2020
Intracellular vincristine levels in lymphoblasts affect treatment outcome in childhood B-lymphoblastic leukaemia: Ma-Spore ALL 2010 studyNan Jiang, Lingzhi Wang, Xiaoqiang Xiang, et al.
Scientific Reports|June 15, 2016
Pharmacogenetics-Guided Phase I Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid TumoursRoss Andrew Soo, Nicholas Syn, Soo-Chin Lee, et al.
Antioxidants & Redox Signaling|August 23, 2013
Manganese superoxide dismutase is a promising target for enhancing chemosensitivity of basal-like breast carcinomaAlan Prem Kumar, Ser Yue Loo, Sung Won Shin, et al.
Theranostics|January 4, 2021
Putting the BRK on breast cancer: From molecular target to therapeuticsHui Li Ang, Yi Yuan, Xianning Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2026
A multicentre phase 2 study of trifluridine/tipiracil in recurrent/metastatic platinum resistant nasopharyngeal carcinomasJia Li Low, Wan Qin Chong, Edwin Pun Hui, et al.
Cancer Letters|July 28, 2016
A novel combinatorial strategy using Seliciclib(®) and Belinostat(®) for eradication of non-small cell lung cancer via apoptosis induction and BID activationPei-Shi Ong, Lingzhi Wang, Deborah Miao-Hui Chia, et al.
Oncotarget|February 4, 2017
Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1Lingzhi Wang, Chong En Linus Chan, Andrea Li-Ann Wong, et al.
Cancer|April 2, 2019
Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potentialRahel Sarah Varughese, Walter Sze-Tung Lam, Ahmad Abdurrahman Bin Hanifah Marican, et al.
Pageof 25